GlassScriptPhysician profile
Selena A Lantry
NPI 1063501880
$2,378.53
in general payments reported to CMS, 2019-2025
22 companies · $286 in 2025
The $286 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $628 · 2020: $265 · 2021: $480 · 2022: $180 · 2023: $351 · 2024: $188 · 2025: $286.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $825.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $824.68 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Galderma Laboratories, L.P. | $712.65 | 2019-2023 | |
| Allergan, INC. | $254.89 | 2019 | |
| Abbvie INC. | $228.74 | 2019-2024 | |
| Myovant Sciences INC. | $140.04 | 2021-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $119.60 | 2020-2023 | |
| Baxter Healthcare | $114.04 | 2023-2025 | Floseal, Tisseel, Perclot |
| Therapeuticsmd, INC. | $89.74 | 2019-2021 | |
| Myriad Women'S Health, INC. | $88.41 | 2023 | Myrisk |
| Mayne Pharma Commercial LLC | $85.32 | 2025 | |
| Hologic Sales and Service, LLC | $77.03 | 2019-2024 | Affirm Prone Biopsy System, Thinprep 2000 Processor |
| Exeltis, USA INC. | $64.49 | 2023-2024 | Slynd |
| Pfizer INC. | $55.52 | 2019-2021 | |
| Supernus Pharmaceuticals, INC. | $54.59 | 2025 | Qelbree |
| Sage Therapeutics, LLC | $54.59 | 2025 | Zurzuvae |
| Sumitomo Pharma America, INC. | $51.18 | 2023-2024 | Myfembree |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amag Pharmaceuticals, INC. | $50.34 | 2019 | |
| Coopersurgical, INC. | $34.38 | 2019-2021 | |
| Meditrina | $24.20 | 2025 | |
| Medicem INC. | $23.17 | 2024 | |
| Lilly USA, LLC | $21.87 | 2025 | Mounjaro, Zepbound |
| Sientra, INC. | $19.99 | 2019 | |
| Agile Therapeutics, INC. | $13.75 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Selena Lantry listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.